Depression in relation to survival among neurosurgical patients with a primary brain tumor: A 5-year follow-up study

Neurosurgery

Volumn 56, Issue 6, 2005, Pages 1234-1241

  Mainio, Arja ^a,b   Hakko, Helinä ^a   Timonen, Markku ^a   Niemelä, Asko ^a   Koivukangas, John ^b   Räsänen, Pirkko ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Depression; Low grade gliomas; Primary brain tumor; Prognostic factors; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BRAIN TUMOR; CANCER SURVIVAL; CLINICAL PRACTICE; DEPRESSION; DISEASE ASSOCIATION; EVALUATION; FEMALE; FINLAND; FOLLOW UP; FUTUROLOGY; GLIOMA; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NEUROSURGERY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; BRAIN NEOPLASMS; DEMOGRAPHY; DEPRESSION; EVALUATION STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROSURGERY; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 20044386698     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000159648.44507.7F     Document Type: Article

References (52)

1. Alderman KJ, Mackay CJ, Lucas EG, Spry WB, Bell B: Factor analysis and reliability studies of Crown-Crisp Experiential Index (CCEI). Br J Med Psychol 56:329-345, 1983.
2. Anderson SI, Taylor R, Whittle IR: Mood disorders in patients after treatment for primary intracranial rumours. Br J Neurosurg 13:480-485, 1999.
3. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 8:77-100, 1988.
4. Bottomley A: Depression in cancer patients: A literature review. Eur J Cancer Care 7:181-191, 1998.
5. Crown S, Crisp AH: A short clinical self-rating scale for psychoneurotic patients: The Middlesex Hospital Questionnaire (MHQ). Br J Psychiatry 112:917-923, 1966.
6. Cruess DG, Antoni MH, McGregor BA, Kilbourn KM, Boyers AE, Alferi SM, Carver CS, Kumar M: Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med 62:304-308, 2000.
7. Elliott SA, Leverton TJ, Sanjack M, Turner H, Cowmeadow P, Hopkins J, Bushnell D: Promoting mental health after childbirth: A controlled trial of primary prevention of postnatal depression. Br J Clin Psychol 39:223-411, 2000.
8. Evans DL, Charney DS: Mood disorders and medical illness: A major public health problem. Biol Psychiatry 54:177-180, 2003.
9. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL: Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681-689, 1993.
10. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM: A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 49:59-72, 1998.
11. Gold PW, Goodwin FK, Chrousos GP: Clinical and biochemical manifestations of depression: Relation to neurobiology of stress. N Engl J Med 319:348-353, 1988.
12. Greer S, Morris T, Pettingale K: Psychological response to breast cancer: Effect on outcome. Lancet 2:785-787, 1979.
13. Haines A, Cooper J, Meade TW: Psychological characteristics and fatal ischemic heart disease. Heart 85:385-389, 2001.
14. Hirschfeld RM: Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs. J Clin Psychiatry 60:326-335, 1999.
15. Horrobin DF, Bennett CN: Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Prostaglandins Leukot Essent Fatty Acids 60:217-234, 1999.
16. Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonzàlez DG: Prognostic factors in glioblastoma multiforme. Strahlenther Onkol 77:283-290, 2001.
17. We E, Peper M, Wowra B, Kunze S: Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol 51:164-174, 1994.
18. Joukamaa M: Crown-Crisp experiential index, a useful tool for measuring neurotic psychopathology. Nord J Psychiatry 46:49-53, 1992.
19. Kaplan CP, Miner ME: Relationships: Importance for patients with cerebral tumours. Brain Inj 14:251-259, 2000.
20. Katon WJ: Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54:216-226, 2003.
21. Kiloh LG, Andrews G, Neilson M: The long-term outcome of depressive illness. Br J Psychiatry 153:752-757, 1988.
22. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System: WHO Classifications. Berlin, Springer Verlag, 1993, ed 2.
23. Levy SM, Herberman RB, Lippman M, D'Angelo T, Lee J: Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 17:67-75, 1991.
24. Lezak MD: Neuropsychological Assessment. New York, Oxford University Press, 1995, ed 3.
25. Liigant A, Kulla A, Linnamägi Ü, Asser T, Kaasik AE: Survival of patients with primary CNS tumours in Estonia. Eur J Cancer 37:1895-1903, 2001.
26. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr: Depression in patients with high-grade glioma: Results of the glioma outcome project. Neurosurgery 54:358-366, 2004.
27. Lutterbach J, Sauerbrei W, Guttenberg R: Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 1:8-15, 2003.
28. Mainio A, Hakko H, Niemelä A, Tuurinkoski T, Koivukangas J, Räsänen P: The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry 74:1278-1282, 2003.
29. Matsui T, Kawamoto K, Iwata M, Kurent JE, Imai T, Ohsugi T, Hirano A: Anatomical and pathological study of the brain by CT scanner: Part 1-Anatomical study of normal brain. Comput Tomogr 1:3-43, 1977.
30. Merzak A, Koochekpour S, Fillion MP, Fillion G, Pilkington GJ: Expression of serotonin receptors in human fetal astrocytes and glioma cell proliferation and migration. Brain Res Mol Brain Res 41:1-7, 1996.
31. Molassiotis A, Van Den Akker O, Milligan D, Goldman J: Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J Psychosom Res 42:275-285, 1997.
32. Nemeroff CB: Recent advances in the neurobiology of depression. Psychopharmacol Bull 36[Suppl 2]:6-23, 2002.
33. Noda M, Yasuda S, Okada M, Higashida H, Shimada A, Iwata N, Ozaki N, Nishikawa K, Shirasawa S, Uchida M, Aoki S, Wada K: Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways. J Neuroochem 84:222-232, 2003.
34. North CA, North RB, Epstein J, Piantadosi S, Wharam MD: Low-grade cerebral astrocytomas survival and quality of life after radiation therapy. Cancer 66:6-14, 1990.
35. Parker G, Roy K, Eyers K: Cognitive behavior therapy for depression? Choose horses for courses. Am J Psychiatry 160:825-834, 2003.
36. Pelletier G, Verhoef MJ, Khatri N, Hagen N: Quality of life in brain tumor patients: The relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41-49, 2002.
37. Petticrew M, Bell R, Hunter D: Influence of psychological coping on survival and recurrence in people with cancer: Systematic review. BMJ 325:1066-1076, 2002.
38. Pettingale K, Morris T, Greer S, Haybittle J: Mental attitudes to cancer: An additional prognostic factor. Lancet 335:49-50, 1990.
39. Pringle AM, Taylor R, Whittle IR: Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13:46-51, 1999.
40. Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF: Validity of clinical trials of antidepressants. Am J Psychiatry 157:327-337, 2000.
41. Ressler KJ, Nemeroff CB: Role of serotonergic and noradrenergic systems in pathophysiology of depression and anxiety disorders. Depress Anxiety 12[Suppl 1]:2-19, 2000.
42. Salo J, Niemelä A, Joukama M, Koivukangas J: Effect of brain tumour laterality on patients' perceived quality of life. J Neurol Neurosurg Psychiatry 72:373-377, 2002.
43. Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracranial glioma: Influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69, 1996.
44. Schwenk TL: Cancer and depression. Oncology 25:505-513, 1998.
45. Spiegel D: Cancer and depression. Br J Psychiatry Suppl 30:109-116, 1996.
46. Spiegel D, Giese-Davis J: Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 54:269-282, 2003.
47. Spiegel D, Bloom JR, Kraemer HC, Gottheil E: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989.
48. Steffens DC, Krishnan KR, Helms MJ: Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis. Depress Anxiety 6:10-18, 1997.
49. Tschuschke V, Hertenstein B, Arnold R, Bunjes D, Denzinger R, Kaechele H: Associations between coping and survival time of adult leukemia patients receiving allogenic bone marrow transplantation: Results of a prospective study. J Psychosom Res 50:277-285, 2001.
50. van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A, Heijnen CJ: Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study. J Psychosom Res 59:280-293, 1997.
51. Weitzner MA: Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 17:285-291, 1999.
52. Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J: Predicting major depression in brain tumor patients. Psychooncology 11:230-238, 2002.